GxP brain
↗Berlin, Germany
GxP brain GmbH is a specialized pharmaceutical software and consulting firm that provides high-quality software services for the life sciences industry. Known as 'The Pharma Software Company,' they focus on GxP-compliant software development, specifically in the areas of clinical trial logistics and supply chain management.
The company's core offerings include Interactive Response Technology (IRT/IVRS/RTSM) for clinical trials, customized software development, and comprehensive validation services. They emphasize 'Quality Thinking' and leverage over 30 years of collective experience to ensure that clinical software meets rigorous regulatory standards for data integrity and patient safety.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Clinical Trial Software & Compliance
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Unfunded
PIPELINE
Modalities:Software, Digital Health Solutions
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Dr. Notghi Contract Research GmbH (Collaborative history in clinical research services)
COMPETITION
Position:Niche Player
Competitors:Veeva Systems, Medidata Solutions, 4G Clinical, Suvoda, Signant Health, Endpoint Clinical
LEADERSHIP
Key Executives:
Nimer Yusef - Managing Director
Scientific Founders:Nimer Yusef
LINKS
Website:gxp-brain.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of GxP brain and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GxP brain. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.